nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—Hydroxyurea—head and neck cancer	0.313	0.408	CbGbCtD
Reboxetine—ABCB1—Vinblastine—head and neck cancer	0.118	0.153	CbGbCtD
Reboxetine—CYP2D6—Vinblastine—head and neck cancer	0.111	0.144	CbGbCtD
Reboxetine—ABCB1—Docetaxel—head and neck cancer	0.097	0.126	CbGbCtD
Reboxetine—CYP3A4—Vinblastine—head and neck cancer	0.0705	0.0919	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—head and neck cancer	0.0581	0.0757	CbGbCtD
Reboxetine—Electrocardiogram change—Fluorouracil—head and neck cancer	0.0103	0.0442	CcSEcCtD
Reboxetine—Sinus tachycardia—Docetaxel—head and neck cancer	0.00527	0.0226	CcSEcCtD
Reboxetine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00465	0.02	CcSEcCtD
Reboxetine—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.0044	0.0189	CcSEcCtD
Reboxetine—Duodenal ulcer—Docetaxel—head and neck cancer	0.00439	0.0189	CcSEcCtD
Reboxetine—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00416	0.0179	CcSEcCtD
Reboxetine—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00366	0.0157	CcSEcCtD
Reboxetine—Speech disorder—Fluorouracil—head and neck cancer	0.00342	0.0147	CcSEcCtD
Reboxetine—Face oedema—Hydroxyurea—head and neck cancer	0.00286	0.0123	CcSEcCtD
Reboxetine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00278	0.0119	CcSEcCtD
Reboxetine—Breast disorder—Hydroxyurea—head and neck cancer	0.00268	0.0115	CcSEcCtD
Reboxetine—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00264	0.0113	CcSEcCtD
Reboxetine—Euphoric mood—Fluorouracil—head and neck cancer	0.00253	0.0109	CcSEcCtD
Reboxetine—Amenorrhoea—Docetaxel—head and neck cancer	0.00241	0.0104	CcSEcCtD
Reboxetine—Dysuria—Hydroxyurea—head and neck cancer	0.0024	0.0103	CcSEcCtD
Reboxetine—Infestation NOS—Hydroxyurea—head and neck cancer	0.00228	0.00982	CcSEcCtD
Reboxetine—Infestation—Hydroxyurea—head and neck cancer	0.00228	0.00982	CcSEcCtD
Reboxetine—Pharyngitis—Vinblastine—head and neck cancer	0.00223	0.00959	CcSEcCtD
Reboxetine—Respiratory failure—Docetaxel—head and neck cancer	0.00216	0.00929	CcSEcCtD
Reboxetine—Hallucination—Hydroxyurea—head and neck cancer	0.00204	0.00877	CcSEcCtD
Reboxetine—Irritability—Fluorouracil—head and neck cancer	0.00204	0.00875	CcSEcCtD
Reboxetine—Muscular weakness—Fluorouracil—head and neck cancer	0.00188	0.00809	CcSEcCtD
Reboxetine—Angiopathy—Hydroxyurea—head and neck cancer	0.00186	0.008	CcSEcCtD
Reboxetine—Chills—Hydroxyurea—head and neck cancer	0.00184	0.00791	CcSEcCtD
Reboxetine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00182	0.00781	CcSEcCtD
Reboxetine—Anaemia—Vinblastine—head and neck cancer	0.00181	0.00778	CcSEcCtD
Reboxetine—Malaise—Vinblastine—head and neck cancer	0.00176	0.00759	CcSEcCtD
Reboxetine—Vertigo—Vinblastine—head and neck cancer	0.00176	0.00756	CcSEcCtD
Reboxetine—Leukopenia—Vinblastine—head and neck cancer	0.00175	0.00753	CcSEcCtD
Reboxetine—Hypertension—Vinblastine—head and neck cancer	0.00169	0.00726	CcSEcCtD
Reboxetine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00166	0.00712	CcSEcCtD
Reboxetine—Anaemia—Hydroxyurea—head and neck cancer	0.00165	0.00709	CcSEcCtD
Reboxetine—Discomfort—Vinblastine—head and neck cancer	0.00165	0.00708	CcSEcCtD
Reboxetine—Infestation—Fluorouracil—head and neck cancer	0.00164	0.00707	CcSEcCtD
Reboxetine—Infestation NOS—Fluorouracil—head and neck cancer	0.00164	0.00707	CcSEcCtD
Reboxetine—Malaise—Hydroxyurea—head and neck cancer	0.00161	0.00692	CcSEcCtD
Reboxetine—Urinary tract infection—Fluorouracil—head and neck cancer	0.0016	0.00687	CcSEcCtD
Reboxetine—Conjunctivitis—Fluorouracil—head and neck cancer	0.0016	0.00687	CcSEcCtD
Reboxetine—Leukopenia—Hydroxyurea—head and neck cancer	0.0016	0.00687	CcSEcCtD
Reboxetine—Epistaxis—Fluorouracil—head and neck cancer	0.00155	0.00667	CcSEcCtD
Reboxetine—Hyponatraemia—Docetaxel—head and neck cancer	0.00155	0.00665	CcSEcCtD
Reboxetine—Sinusitis—Fluorouracil—head and neck cancer	0.00154	0.00663	CcSEcCtD
Reboxetine—Anorexia—Vinblastine—head and neck cancer	0.00152	0.00655	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00151	0.00649	CcSEcCtD
Reboxetine—Discomfort—Hydroxyurea—head and neck cancer	0.0015	0.00645	CcSEcCtD
Reboxetine—Rhinitis—Fluorouracil—head and neck cancer	0.00148	0.00636	CcSEcCtD
Reboxetine—Pharyngitis—Fluorouracil—head and neck cancer	0.00146	0.0063	CcSEcCtD
Reboxetine—Infection—Hydroxyurea—head and neck cancer	0.00145	0.00622	CcSEcCtD
Reboxetine—Paraesthesia—Vinblastine—head and neck cancer	0.00143	0.00617	CcSEcCtD
Reboxetine—Dehydration—Docetaxel—head and neck cancer	0.00143	0.00616	CcSEcCtD
Reboxetine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00143	0.00614	CcSEcCtD
Reboxetine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00142	0.00611	CcSEcCtD
Reboxetine—Skin disorder—Hydroxyurea—head and neck cancer	0.00141	0.00608	CcSEcCtD
Reboxetine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00141	0.00605	CcSEcCtD
Reboxetine—Breast disorder—Docetaxel—head and neck cancer	0.00139	0.00598	CcSEcCtD
Reboxetine—Anorexia—Hydroxyurea—head and neck cancer	0.00139	0.00597	CcSEcCtD
Reboxetine—Decreased appetite—Vinblastine—head and neck cancer	0.00139	0.00597	CcSEcCtD
Reboxetine—Constipation—Vinblastine—head and neck cancer	0.00137	0.00587	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00136	0.00584	CcSEcCtD
Reboxetine—Feeling abnormal—Vinblastine—head and neck cancer	0.00132	0.00566	CcSEcCtD
Reboxetine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00131	0.00562	CcSEcCtD
Reboxetine—Dyspnoea—Hydroxyurea—head and neck cancer	0.0013	0.00558	CcSEcCtD
Reboxetine—Somnolence—Hydroxyurea—head and neck cancer	0.0013	0.00557	CcSEcCtD
Reboxetine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00128	0.00551	CcSEcCtD
Reboxetine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00127	0.00544	CcSEcCtD
Reboxetine—Abdominal pain—Vinblastine—head and neck cancer	0.00126	0.00543	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00126	0.00541	CcSEcCtD
Reboxetine—Constipation—Hydroxyurea—head and neck cancer	0.00125	0.00536	CcSEcCtD
Reboxetine—Weight decreased—Docetaxel—head and neck cancer	0.0012	0.00518	CcSEcCtD
Reboxetine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0012	0.00516	CcSEcCtD
Reboxetine—Anaemia—Fluorouracil—head and neck cancer	0.00119	0.00511	CcSEcCtD
Reboxetine—Infestation NOS—Docetaxel—head and neck cancer	0.00119	0.0051	CcSEcCtD
Reboxetine—Infestation—Docetaxel—head and neck cancer	0.00119	0.0051	CcSEcCtD
Reboxetine—Hypersensitivity—Vinblastine—head and neck cancer	0.00118	0.00506	CcSEcCtD
Reboxetine—Conjunctivitis—Docetaxel—head and neck cancer	0.00115	0.00496	CcSEcCtD
Reboxetine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00115	0.00495	CcSEcCtD
Reboxetine—Leukopenia—Fluorouracil—head and neck cancer	0.00115	0.00494	CcSEcCtD
Reboxetine—Asthenia—Vinblastine—head and neck cancer	0.00115	0.00493	CcSEcCtD
Reboxetine—Epistaxis—Docetaxel—head and neck cancer	0.00112	0.00481	CcSEcCtD
Reboxetine—Chest pain—Fluorouracil—head and neck cancer	0.00109	0.0047	CcSEcCtD
Reboxetine—Diarrhoea—Vinblastine—head and neck cancer	0.00109	0.0047	CcSEcCtD
Reboxetine—Discomfort—Fluorouracil—head and neck cancer	0.00108	0.00465	CcSEcCtD
Reboxetine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00107	0.00461	CcSEcCtD
Reboxetine—Rhinitis—Docetaxel—head and neck cancer	0.00107	0.00459	CcSEcCtD
Reboxetine—Confusional state—Fluorouracil—head and neck cancer	0.00106	0.00455	CcSEcCtD
Reboxetine—Pharyngitis—Docetaxel—head and neck cancer	0.00106	0.00455	CcSEcCtD
Reboxetine—Dizziness—Vinblastine—head and neck cancer	0.00106	0.00454	CcSEcCtD
Reboxetine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00105	0.00452	CcSEcCtD
Reboxetine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00105	0.0045	CcSEcCtD
Reboxetine—Asthenia—Hydroxyurea—head and neck cancer	0.00105	0.00449	CcSEcCtD
Reboxetine—Urethral disorder—Docetaxel—head and neck cancer	0.00104	0.00449	CcSEcCtD
Reboxetine—Infection—Fluorouracil—head and neck cancer	0.00104	0.00448	CcSEcCtD
Reboxetine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00103	0.00442	CcSEcCtD
Reboxetine—Visual impairment—Docetaxel—head and neck cancer	0.00103	0.00441	CcSEcCtD
Reboxetine—Tachycardia—Fluorouracil—head and neck cancer	0.00102	0.0044	CcSEcCtD
Reboxetine—Vomiting—Vinblastine—head and neck cancer	0.00102	0.00437	CcSEcCtD
Reboxetine—Headache—Vinblastine—head and neck cancer	0.001	0.0043	CcSEcCtD
Reboxetine—Anorexia—Fluorouracil—head and neck cancer	0.000999	0.0043	CcSEcCtD
Reboxetine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000997	0.00429	CcSEcCtD
Reboxetine—Eye disorder—Docetaxel—head and neck cancer	0.000995	0.00428	CcSEcCtD
Reboxetine—Cardiac disorder—Docetaxel—head and neck cancer	0.000989	0.00425	CcSEcCtD
Reboxetine—Hypotension—Fluorouracil—head and neck cancer	0.00098	0.00421	CcSEcCtD
Reboxetine—Angiopathy—Docetaxel—head and neck cancer	0.000966	0.00416	CcSEcCtD
Reboxetine—Dizziness—Hydroxyurea—head and neck cancer	0.000963	0.00414	CcSEcCtD
Reboxetine—Immune system disorder—Docetaxel—head and neck cancer	0.000962	0.00414	CcSEcCtD
Reboxetine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00096	0.00413	CcSEcCtD
Reboxetine—Chills—Docetaxel—head and neck cancer	0.000956	0.00411	CcSEcCtD
Reboxetine—Nausea—Vinblastine—head and neck cancer	0.000949	0.00408	CcSEcCtD
Reboxetine—Insomnia—Fluorouracil—head and neck cancer	0.000948	0.00408	CcSEcCtD
Reboxetine—Paraesthesia—Fluorouracil—head and neck cancer	0.000942	0.00405	CcSEcCtD
Reboxetine—Dyspnoea—Fluorouracil—head and neck cancer	0.000935	0.00402	CcSEcCtD
Reboxetine—Mental disorder—Docetaxel—head and neck cancer	0.000933	0.00401	CcSEcCtD
Reboxetine—Somnolence—Fluorouracil—head and neck cancer	0.000932	0.00401	CcSEcCtD
Reboxetine—Malnutrition—Docetaxel—head and neck cancer	0.000927	0.00399	CcSEcCtD
Reboxetine—Vomiting—Hydroxyurea—head and neck cancer	0.000926	0.00398	CcSEcCtD
Reboxetine—Dyspepsia—Fluorouracil—head and neck cancer	0.000923	0.00397	CcSEcCtD
Reboxetine—Rash—Hydroxyurea—head and neck cancer	0.000918	0.00395	CcSEcCtD
Reboxetine—Dermatitis—Hydroxyurea—head and neck cancer	0.000918	0.00395	CcSEcCtD
Reboxetine—Headache—Hydroxyurea—head and neck cancer	0.000913	0.00392	CcSEcCtD
Reboxetine—Decreased appetite—Fluorouracil—head and neck cancer	0.000911	0.00392	CcSEcCtD
Reboxetine—Dysgeusia—Docetaxel—head and neck cancer	0.000908	0.0039	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000905	0.00389	CcSEcCtD
Reboxetine—Nausea—Hydroxyurea—head and neck cancer	0.000865	0.00372	CcSEcCtD
Reboxetine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000864	0.00371	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—head and neck cancer	0.000857	0.00368	CcSEcCtD
Reboxetine—Urticaria—Fluorouracil—head and neck cancer	0.000833	0.00358	CcSEcCtD
Reboxetine—Syncope—Docetaxel—head and neck cancer	0.000832	0.00358	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—head and neck cancer	0.00083	0.00357	CcSEcCtD
Reboxetine—Body temperature increased—Fluorouracil—head and neck cancer	0.000829	0.00356	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—head and neck cancer	0.000819	0.00352	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—head and neck cancer	0.000815	0.0035	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—head and neck cancer	0.000801	0.00344	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—head and neck cancer	0.000789	0.00339	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000784	0.00337	CcSEcCtD
Reboxetine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000773	0.00332	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—head and neck cancer	0.000772	0.00332	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—head and neck cancer	0.000763	0.00328	CcSEcCtD
Reboxetine—Infection—Docetaxel—head and neck cancer	0.000752	0.00323	CcSEcCtD
Reboxetine—Shock—Docetaxel—head and neck cancer	0.000745	0.0032	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—head and neck cancer	0.000742	0.00319	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—head and neck cancer	0.000739	0.00318	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—head and neck cancer	0.000735	0.00316	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—head and neck cancer	0.000721	0.0031	CcSEcCtD
Reboxetine—Diarrhoea—Fluorouracil—head and neck cancer	0.000717	0.00308	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—head and neck cancer	0.000707	0.00304	CcSEcCtD
Reboxetine—Dizziness—Fluorouracil—head and neck cancer	0.000693	0.00298	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—head and neck cancer	0.000684	0.00294	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—head and neck cancer	0.00068	0.00292	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—head and neck cancer	0.000675	0.0029	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—head and neck cancer	0.000673	0.00289	CcSEcCtD
Reboxetine—Vomiting—Fluorouracil—head and neck cancer	0.000667	0.00287	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—head and neck cancer	0.000666	0.00286	CcSEcCtD
Reboxetine—Rash—Fluorouracil—head and neck cancer	0.000661	0.00284	CcSEcCtD
Reboxetine—Dermatitis—Fluorouracil—head and neck cancer	0.000661	0.00284	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—head and neck cancer	0.000658	0.00283	CcSEcCtD
Reboxetine—Headache—Fluorouracil—head and neck cancer	0.000657	0.00282	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000653	0.00281	CcSEcCtD
Reboxetine—Constipation—Docetaxel—head and neck cancer	0.000647	0.00278	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—head and neck cancer	0.000624	0.00268	CcSEcCtD
Reboxetine—Nausea—Fluorouracil—head and neck cancer	0.000623	0.00268	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000619	0.00266	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—head and neck cancer	0.000598	0.00257	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—head and neck cancer	0.000598	0.00257	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—head and neck cancer	0.000558	0.0024	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—head and neck cancer	0.000543	0.00233	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—head and neck cancer	0.000518	0.00223	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—head and neck cancer	0.0005	0.00215	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—head and neck cancer	0.000481	0.00207	CcSEcCtD
Reboxetine—Rash—Docetaxel—head and neck cancer	0.000477	0.00205	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—head and neck cancer	0.000477	0.00205	CcSEcCtD
Reboxetine—Headache—Docetaxel—head and neck cancer	0.000474	0.00204	CcSEcCtD
Reboxetine—Nausea—Docetaxel—head and neck cancer	0.00045	0.00193	CcSEcCtD
